Through the 90-day period concluding February 07, 2026, Aurinia Pharmaceuticals's top three insider stakeholders include Director Kevin Tang (11.33Mn shares), Chief Executive Officer Peter Greenleaf (1.85Mn shares), Chief Operating Officer Matthew Maxwell Donley (695.80K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Kevin Tang | 11,329,500 | 05 Aug, 2025 | |
| Peter Greenleaf | Chief Executive Officer | 1,845,037 | 05 Jan, 2026 |
| Matthew Maxwell Donley | Chief Operating Officer | 695,801 | 05 Jan, 2026 |
| Joseph M Miller | Chief Financial Officer | 589,127 | 05 Jan, 2026 |
| Stephen P. Robertson | Evp And General Counsel | 517,934 | 05 Jan, 2026 |
| Scott Michael Habig | Chief Commercial Officer | 456,338 | 08 Aug, 2024 |
| Volker Knappertz | Evp And Research And Development | 319,128 | 29 Feb, 2024 |
| Michael Robert Martin | Chief Business Officer | 259,162 | 06 Mar, 2023 |
| Greg Keenan | Svp And Chief Medical Officer | 121,932 | 03 Feb, 2026 |
| Neil Solomons | Chief Medical Officer | 90,953 | 04 Mar, 2022 |
| George M Jr Milne | 78,733 | 23 May, 2023 | |
| Robert Bindert Huizinga | Evp Of Research | 69,379 | 04 Mar, 2022 |
| David R.W. Jayne | 56,499 | 25 Nov, 2024 | |
| Daniel Billen | 28,141 | 22 May, 2024 | |
| Jill Leversage | 25,053 | 25 Nov, 2024 | |
| Karen L. Smith | 24,807 | 25 Nov, 2024 | |
| Jeffrey Allen Bailey | 22,775 | 24 Nov, 2025 | |
| R. Hector Mackay-Dunn | 18,595 | 22 May, 2024 | |
| Brinda Balakrishnan | 17,523 | 22 May, 2024 | |
| Craig A Johnson | 14,592 | 24 Nov, 2025 | |
| Massimilano Colao | Chief Commercial Officer | 13,495 | 04 Mar, 2022 |
| Joseph P Hagan | 11,961 | 23 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Greg Keenan | Common Stock | D | 11,552 | $14.53 | 121,932 | D | F |
| 02 Jan, 2026 | Peter Greenleaf | Common Stock | D | 113,169 | $15.95 | 1,845,037 | D | F |
| 02 Jan, 2026 | Peter Greenleaf | Common Stock | A | 165,384 | $0.00 | 1,954,329 | D | A |
| 02 Jan, 2026 | Matthew Maxwell Donley | Common Stock | D | 42,787 | $15.95 | 695,801 | D | F |
| 02 Jan, 2026 | Matthew Maxwell Donley | Common Stock | A | 54,166 | $0.00 | 734,631 | D | A |
| 02 Jan, 2026 | Joseph M Miller | Common Stock | D | 40,161 | $15.95 | 589,127 | D | F |
| 02 Jan, 2026 | Joseph M Miller | Common Stock | A | 49,038 | $0.00 | 626,399 | D | A |
| 02 Jan, 2026 | Stephen P. Robertson | Common Stock | A | 48,558 | $0.00 | 557,434 | D | A |
| 02 Jan, 2026 | Stephen P. Robertson | Common Stock | D | 40,385 | $15.95 | 517,934 | D | F |
| 21 Nov, 2025 | Craig A Johnson | Common Shares | D | 6,039 | $15.68 | 14,592 | D | F |
| 21 Nov, 2025 | Craig A Johnson | - | - | 14,592 | D | |||
| 21 Nov, 2025 | Jeffrey Allen Bailey | Common Shares | D | 2,716 | $15.68 | 22,775 | D | F |
| 05 Aug, 2025 | Kevin Tang | Common Shares | A | 200,000 | $11.68 | 11,329,500 | I | P |
| 05 Aug, 2025 | Kevin Tang | - | - | 11,329,500 | I | |||
| 04 Aug, 2025 | Kevin Tang | - | - | 11,129,500 | I | |||
| 04 Aug, 2025 | Kevin Tang | Common Shares | A | 100,000 | $11.34 | 11,129,500 | I | P |
| 01 Aug, 2025 | Kevin Tang | Common Shares | A | 1,000,000 | $10.12 | 11,029,500 | I | P |
| 01 Aug, 2025 | Kevin Tang | - | - | 11,029,500 | I | |||
| 01 Aug, 2025 | Greg Keenan | Common Stock | D | 20,000 | $10.50 | 133,484 | D | S |
| 07 Mar, 2025 | Greg Keenan | Common Stock | D | 8,305 | $8.23 | 153,484 | D | S |